QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations

NCT06715124 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

237

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: QTX3544
COMBINATION_PRODUCT: Cetuximab

Sponsor

Quanta Therapeutics